trial

A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

NCTId NCT00780585
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 95 (actual)
Sponsored by Merck Sharp & Dohme LLC
Primary completion 2009-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
95 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2007-04
Primary completion
2009-01
Eligibility
ALL

Interventions & indications

Drugs
SCH 900460

Sponsors

Merck Sharp & Dohme LLCLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
95
Phase
NA
Primary Completion Date
2009-01
Status
COMPLETED
relationships
The graph out of here
drug
SCH 900460
drug
lead_sponsor
Merck Sharp & Dohme LLC
company
indication
Psychosis
indication
Psychotic Disorders
indication